Search in:

Adipocyte Volume 4, 2015 - Issue 4

Submit an article Journal homepage

Open access

6,633

Views

CrossRef citations to date

Altmetric

Review

Is immunity a mechanism contributing to statin-induced diabetes?

Brandyn D HenriksboDepartment of Biochemistry and Biomedical Sciences; McMaster University; Hamilton, ON, Canada

Jonathan D SchertzerDepartment of Biochemistry and Biomedical Sciences; McMaster University; Hamilton, ON, CanadaCorrespondence[email protected]

Pages 232-238 | Received 18 Dec 2014, Accepted 23 Feb 2015, Published online: 20 Apr 2015

Cite this article
https://doi.org/10.1080/21623945.2015.1024394
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (30)

Sungji Cho, Fan Ying & Gary Sweeney. (2023) Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease. Biomedical Journal 46:5, pages 100624.
Crossref

Tove Selvin, Malin Berglund, Lena Lenhammar, Malin Jarvius, Peter Nygren, Mårten Fryknäs, Rolf Larsson & Claes R Andersson. (2023) Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death. BMC Cancer 23:1.
Crossref

Gaber El-Saber Batiha, Ali I. Al-Gareeb, Damilare Rotimi, Oluyomi Stephen Adeyemi & Hayder M. Al-kuraishy. (2022) Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer. Scientific African 18, pages e01407.
Crossref

Oelfah Patel, Christo J. F. Muller, Elizabeth Joubert, Bernd Rosenkranz, Johan Louw & Charles Awortwe. (2022) Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model. Frontiers in Clinical Diabetes and Healthcare 3.
Crossref

Ali Mahmoudi, Sahar Heydari, Yuliya V. Markina, George E. Barreto & Amirhossein Sahebkar. (2022) Role of statins in regulating molecular pathways following traumatic brain injury: A system pharmacology study. Biomedicine & Pharmacotherapy 153, pages 113304.
Crossref

Gaber El-Saber Batiha, Dr. Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Damilare Rotimi, Oluyomi Stephen Adeyemi & Hayder M. Al-kuraishy. (2021) WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer. Scientific African, pages e01084.
Crossref

Aayush Sehgal, Tapan Behl, Ishnoor Kaur, Sukhbir Singh, Neelam Sharma & Lotfi Aleya. (2021) Targeting NLRP3 inflammasome as a chief instigator of obesity, contributing to local adipose tissue inflammation and insulin resistance. Environmental Science and Pollution Research 28:32, pages 43102-43113.
Crossref

Khadijeh Koushki, Sanaz Keshavarz Shahbaz, Kazem Mashayekhi, Mahvash Sadeghi, Zeinab Deris Zayeri, Mahdieh Yousefi Taba, Maciej Banach, Khalid Al-Rasadi, Thomas P. Johnston & Amirhossein Sahebkar. (2020) Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways. Clinical Reviews in Allergy & Immunology 60:2, pages 175-199.
Crossref

Nathan O. Stitziel, Jenny E. Kanter & Karin E. Bornfeldt. (2020) Emerging Targets for Cardiovascular Disease Prevention in Diabetes. Trends in Molecular Medicine 26:8, pages 744-757.
Crossref

Brandyn D. Henriksbo, Akhilesh K. Tamrakar, Jobanjit S. Phulka, Nicole G. Barra & Jonathan D. Schertzer. (2020) Statins activate the NLRP3 inflammasome and impair insulin signaling via p38 and mTOR. American Journal of Physiology-Endocrinology and Metabolism 319:1, pages E110-E116.
Crossref

Rafael I. Jaén, Almudena Val-Blasco, Patricia Prieto, Marta Gil-Fernández, Tarik Smani, José Luis López-Sendón, Carmen Delgado, Lisardo Boscá & María Fernández-Velasco. (2020) Innate Immune Receptors, Key Actors in Cardiovascular Diseases. JACC: Basic to Translational Science 5:7, pages 735-749.
Crossref

Nicole G. Barra, Brandyn D. Henriksbo, Fernando F. Anhê & Jonathan D. Schertzer. (2020) The NLRP3 inflammasome regulates adipose tissue metabolism. Biochemical Journal 477:6, pages 1089-1107.
Crossref

Pu Hong, Ruo-Nan Gu, Feng-Xian Li, Xiao-Xing Xiong, Wen-Bin Liang, Zhi-Jian You & Hong-Fei Zhang. (2019) NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. Journal of Neuroinflammation 16:1.
Crossref

Karina GasbarrinoAnouar HafianeHuaien ZhengStella S. Daskalopoulou. (2019) Intensive Statin Therapy Compromises the Adiponectin-AdipoR Pathway in the Human Monocyte-Macrophage Lineage. Stroke 50:12, pages 3609-3617.
Crossref

Paula M.F. dos Anjos, Caroline M.O. Volpe, Thaís C. Miranda & José A. Nogueira-Machado. (2019) Atorvastatin Inhibited ROS Generation and Increased IL-1β And IL-6 Release by Mononuclear Cells from Diabetic Patients. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:8, pages 1207-1215.
Crossref

Liberale, Carbone, Camici & Montecucco. (2019) IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy. Journal of Clinical Medicine 8:11, pages 1764.
Crossref

Veronica Azemawah, Mohammad Reza Movahed, Patrick Centuori, Ryan Penaflor, Pascal L. Riel, Steven Situ, Mehrdad Shadmehr & Mehrnoosh Hashemzadeh. (2019) State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications. Cardiovascular Drugs and Therapy 33:5, pages 625-639.
Crossref

Negin Parsamanesh, Maryam Moossavi, Afsane Bahrami, Mohammad Fereidouni, George Barreto & Amirhossein Sahebkar. (2019) NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy. International Immunopharmacology 73, pages 146-155.
Crossref

Alicia J. Jenkins, Emma Scott, Jordan Fulcher, Gary Kilov & Andrzej S. Januszewski. 2019. Comprehensive Cardiovascular Medicine in the Primary Care Setting. Comprehensive Cardiovascular Medicine in the Primary Care Setting 113 177 .

Joseph F. Cavallari, Fernando F. Anhê, Kevin P. Foley, Emmanuel Denou, Rebecca W. Chan, Dawn M. E. Bowdish & Jonathan D. Schertzer. (2018) Targeting macrophage scavenger receptor 1 promotes insulin resistance in obese male mice. Physiological Reports 6:22, pages e13930.
Crossref

Anna J. Boland, Nisha Gangadharan, Pierce Kavanagh, Linda Hemeryck, Jennifer Kieran, Michael Barry, Patrick T. Walsh & Margaret Lucitt. (2018) Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals. Journal of Cardiovascular Pharmacology and Therapeutics 23:6, pages 509-517.
Crossref

Muhammad Imran, Odile Sergent, Arnaud Tête, Isabelle Gallais, Martine Chevanne, Dominique Lagadic-Gossmann & Normand Podechard. (2018) Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae. Biomolecules 8:2, pages 26.
Crossref

Ki Hoon Han. (2018) Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism. Korean Circulation Journal 48:11, pages 951.
Crossref

Yogita Rochlani, Ajoe John Kattoor, Naga Venkata Pothineni, Raga Deepak Reddy Palagiri, Francesco Romeo & Jawahar L. Mehta. (2017) Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention. The American Journal of Cardiology 120:7, pages 1122-1128.
Crossref

Marin Jane McBrideKevin P. Foley, Donna M. D’Souza, Yujin E. LiTrevor C. Lau, Thomas J. Hawke & Jonathan D. Schertzer. (2017) The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice. American Journal of Physiology-Endocrinology and Metabolism 313:2, pages E222-E232.
Crossref

Chong-Rong Qiu, Qiang Fu, Jian Sui, Qian Zhang, Peng Wei, Yan Wu, Ke Zhu, Yi Lu & Peng Wan. (2016) Analysis of Serum Endothelial Cell-Specific Molecule 1 (Endocan) Level in Type 2 Diabetes Mellitus With Acute ST-Segment Elevation Myocardial Infarction and its Correlation. Angiology 68:1, pages 74-78.
Crossref

Scott B. Widenmaier & Gökhan S. Hotamışlıgil. (2016) Immune Cell Intolerance for Excess Cholesterol. Immunity 45:6, pages 1186-1188.
Crossref

Yochai Birnbaum, Gilad D. Birnbaum, Itamar Birnbaum, Sven Nylander & Yumei Ye. (2016) Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine. Cardiovascular Drugs and Therapy 30:6, pages 539-550.
Crossref

Ishak A. Mansi, Jenny English, Song Zhang, Eric M. Mortensen & Ethan A. Halm. (2016) Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study. Drug Safety 39:6, pages 543-559.
Crossref

Monalisa Debnath, Shruti Agrawal, Aruna Agrawal & G.P. Dubey. (2016) Metaflammatory responses during obesity: Pathomechanism and treatment. Obesity Research & Clinical Practice 10:2, pages 103-113.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Is immunity a mechanism contributing to statin-induced diabetes?

Articles from other publishers (30)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Is immunity a mechanism contributing to statin-induced diabetes?

Citations (30)

Articles from other publishers (30)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date